Research News and Research

RSS

Cyntellect releases new cell cytometry system

Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the Company’s new platform for non-invasive in situ live cell imaging.

21 Sep 2009

FDA approves Neuralstem's IND for commencing a stem cell trial to treat Amyotrophic Lateral Sclerosis

Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to commence a Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells.

21 Sep 2009

Maxygen completes joint venture transaction with Astellas Pharma

Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.

21 Sep 2009

Swedish researcher to receive Fernström Foundation's Nordic Prize

Internationally renowned Swedish researcher Professor Jan-Åke Gustafsson, from KI and the University of Houston, is this year's recipient of the Fernström Foundation's Nordic Prize. The prize, which is worth SEK 1 million, is one of Scandinavia's most prestigious medical prizes.

21 Sep 2009

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA(R) (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care.

21 Sep 2009

Open letter to shareholders from London & Pacific Healthcare

Throughout this past year, the Board of Directors, in conjunction with the management team, key investors, business partners, employees, and experienced market consultants, has explored a variety of alternatives for significantly increasing shareholder value.

21 Sep 2009

Impax Laboratories challenges Galderma Laboratories' patents

Impax Laboratories, Inc. confirms that it has initiated a challenge of the patents listed by Galderma Laboratories, L.P. in connection with its ORACEA® (doxycycline) delayed-release capsules, 40 mg.

21 Sep 2009

Study reveals that Europe must change perspectives towards food security

A new report by leading food and sustainability scientists calls for Europe to take a new approach on food security, prioritizing health and sustainability in research and using a holistic view when making policy. The report has been jointly chaired by Peter Raspor, professor of food science and technology at the University of Ljubljana, Slovenia and Rudy Rabbinge, professor of sustainable development and systems innovation at Wageningen University, the Netherlands.

21 Sep 2009

Results of Phase 1 study of Oral AEZS-112 announced by Aeterna Zentaris

Æterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) ("the Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the completion of a Phase 1 study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.

21 Sep 2009

SmarterTravel releases precautionary checklist for travelers regarding swine flu

SmarterTravel(R), a comprehensive travel advice resource for the budget-conscious traveler, today released a checklist of strategies for staying safe while traveling during this highly anticipated flu season.

21 Sep 2009

Ontarians support research involving biotechnology

Ontarians overwhelmingly value biotechnology’s contribution to their lives and the economy, BIOTECanada told Minister Milloy and an audience of over 150 business leaders at the launch of the sixth annual National Biotechnology Week.

21 Sep 2009

IUPUI offers new graduate program in international research ethics

A "Concentration in International Research Ethics" will be offered by the Department of Philosophy in the IU School of Liberal Arts at Indiana University-Purdue University Indianapolisand the Indiana Center for Bioethics.

21 Sep 2009

Vaccine Global Congress organized by Elsevier's Vaccine journal

Elsevier, a leading publisher of scientific, technical and medical information products and services, announced today, that its journal Vaccine, the most comprehensive and pre-eminent journal for those interested in vaccines and vaccination, will organize the 3rd Vaccine Global Congress from 4-6 October, 2009, in Singapore.

21 Sep 2009

Study reveals that daily commuting may lead to mosquito-borne diseases

University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.

21 Sep 2009

Invatec launches a 3-dimensional distal Embolic Protection System for Carotid Artery Stenting

Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031’’) and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.

21 Sep 2009

Research counters criticisms of Canadian health care system

Bloomberg reports that allegations that the Canadian health care system offers inferior treatment, rationing and long lines are wrong, according to wide-ranging and long-standing research.

21 Sep 2009

Hypertension Diagnostics' revenue decreases by 9.2% for the fiscal year 2009

Hypertension Diagnostics, Inc. (OTCBB: HDII), today announced audited financial results for the fiscal year ended June 30, 2009.

21 Sep 2009

ICTs play a major role in the health care sector

Today the GridTalk project launches its 8th GridBriefing at the Enabling Grids for E-sciencE (EGEE) conference in Barcelona. The report covers how information and communication technologies (ICTs), particularly computing grids, are used in the health and biomedical sectors of European research. EGEE has supported this research community since the project's birth and it is the second largest user group after physics research.

21 Sep 2009

Bioniche Life Sciences' revenue increases by 21% for the fiscal year 2009

Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2009 fiscal year ended June 30, 2009.

21 Sep 2009

Study reveals that allergies are a major health issue in Sweden

Asthma, nasal symptoms and eczema is a major public health problem in Sweden, not least among young people. Half of all teenagers are affected in Västra Götaland County in West Sweden.

21 Sep 2009